Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

The book is a valuable resource for understanding hair and scalp problems but could be updated with more information on certain conditions.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Uterine transplants for transgender women are feasible but need more research.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.